STOCK TITAN
  1. Home
  2. News
  3. RDHL

Redhill Biopharma Ltd. - RDHL STOCK NEWS

IMPACT
SENTIMENT
RDHL : Nasdaq RDHL : Nasdaq
RedHill Biopharma Announces Closing of $3.8 Million Registered Direct Offering and Warrant Exercise
offering
IMPACT
SENTIMENT
RDHL : Nasdaq RDHL : Nasdaq
RedHill Biopharma Announces Registered Direct Offering and Warrant Exercise for $3.8 Million Gross Proceeds
offering
IMPACT
SENTIMENT
RDHL : Nasdaq RDHL : Nasdaq
RedHill Announces Additional U.S. Government Funding for Opaganib Nuclear Countermeasure Development
IMPACT
SENTIMENT
RDHL : Nasdaq
Phil and RedHill Biopharma Partner to Increase Access to Talicia®
partnership
IMPACT
SENTIMENT
RDHL : Nasdaq RDHL : Nasdaq
RedHill Provides R&D Update
IMPACT
SENTIMENT
RDHL : Nasdaq RDHL : Nasdaq
RedHill Biopharma Receives NASDAQ Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
IMPACT
SENTIMENT
RDHL : Nasdaq RDHL : Nasdaq
RedHill Publishes New Talicia® Data on Generic Non-Bioequivalence in AP&T and Presents New Dosing Data at Digestive Disease Week
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill's RHB-102 (BEKINDA®) and Opaganib Granted New Patents in Oncology Setting
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma Announces Q4/22 & Full-Year 2022 Results and Operational Highlights
IMPACT
SENTIMENT
RDHL : Nasdaq
Global Antibiotics Market Report 2023: Featuring Bayer, Fujisawa Pharmaceutical, GlaxoSmithKline, Merck and More
Stock RDHL logo
Redhill Biopharma Ltd.

Nasdaq:RDHL

RDHL Rankings

#7123 Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

RDHL Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Israel
21 Haarbaa St

About RDHL

redhill biopharma is a biopharmaceutical company focused primarily on development of late clinical-stage new, improved and patented formulations of existing drugs. redhill has an experienced management team, board of directors and advisory board based in israel, the us, canada and europe, with successful track record at big and small pharma of bringing patented drugs to the market, as well as extensive managerial, financial, and transactional expertise